Teva Launches Generic Version of Viagra® (sildenafil) in Countries Across Europe JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd (NYSE:TEVA) announced today that it had launched a generic version of Viagra® (sildenafil) immediately on patent expiry in Germany, the United Kingdom, Italy, the Netherlands, Switzerland, Ireland, Austria, Belgium and Denmark. The company had already launched the product in Spain, Canada and certain other countries. Dipankar ...
June 24, 2013 - Business Wire
Actavis Launches Generic Viagra(R) in Europe as Patents Expire Actavis, Inc. , a leading global specialty pharmaceutical company, today announced that it has launched Sildenafil Actavis 25 mg, 50 mg and 100 mg tablets in 11 major Western-European markets on market ...
June 24, 2013 - Marketwired via Yahoo! Finance
Paul Klee in Times of India Originally, we were testing sildenafil, the active drug in Viagra, as a cardiovascular drug and for its ability to lower blood pressure,said Dr Brian Klee, senior medical director at Pfizer. "But one thing that was found during those...